spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Levetiracetam 

 HSMN NewsFeed - 24 Mar 2016
Ajanta Pharma Announces the Launch of Levetiracetam Tablets
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 22 Mar 2016
First FDA-Approved Medicine Manufactured Using 3D Printing Technology Now Available
Biopharmaceuticals Drug Delivery Neurology Product Launch
 HSMN NewsFeed - 3 Aug 2015
FDA Approves the First 3D Printed Drug Product
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 21 Feb 2013
Top-Line Data Show Lyrica Met Primary Endpoint in Clinical Trial as Adjunctive Therapy versus Levetiracetam in Patients with Partial Onset Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 May 2012
APP Pharmaceuticals Acquires Three Products from Nexus
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 10 Apr 2009
New Keppra XR(TM) Dosage Strength Offers Simplified Treatment Option for People Living With Partial-Onset Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Feb 2009
Dr. Reddy's Announces Five ANDA Approvals and Generic Product Launches in the US Market
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Jan 2009
Actavis Receives Approval of Levetiracetam Oral Solution in the U.S.
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Jan 2009
Lupin is Granted USFDA Approval for Levetiracetam Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 4 Nov 2008
Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra(R) and Launches Immediately
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 15 Sep 2008
Keppra XR(TM) Approved in the U.S.
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 10 Jun 2008
Otsuka and UCB agreed to co-develop and co-promote Keppra(R) and Cimzia(R) in Japan
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2008
US FDA grants pediatric exclusivity for UCB's Keppra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Dec 2007
UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Jul 2007
Neuren to Obtain Late Stage Compound Through Hamilton Pharmaceuticals Acquisition
Biopharmaceuticals Acquisitions Neurology
 HSMN NewsFeed - 20 Apr 2007
UCB Announces Positive Top-Line Phase III Results for Keppra(R) as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Mar 2007
Keppra(R) Approved for US Epilepsy Patients with One of the Most Debilitating Seizure Types
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Jan 2007
More European Patients With Epilepsy to Benefit From Keppra(R)
Biopharmaceuticals Regulatory Neurology
 HSMN NewsFeed - 3 Jul 2006
A Key Regulatory Milestone for Keppra
Biopharmaceuticals Regulatory Neurology
 HSMN NewsFeed - 15 May 2006
European Commission Approves Keppra(R) for Use as Adjunctive Therapy in the Treatment of Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy
Biopharmaceuticals Neurology Regulatory
Return to NewsFeed  

 Additional items found! 13

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 13 additional stories matching:
Levetiracetam
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.